ONCOGENEX PHARMACEUTICALS IN's ticker is and the CUSIP is 68230A906. A total of 2 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $4,000 | -20.0% | 10,800 | 0.0% | 0.00% | – |
| Q1 2017 | $5,000 | +25.0% | 10,800 | +47.9% | 0.00% | – |
| Q3 2016 | $4,000 | -42.9% | 7,300 | 0.0% | 0.00% | – |
| Q2 2016 | $7,000 | +250.0% | 7,300 | +217.4% | 0.00% | – |
| Q1 2016 | $2,000 | -33.3% | 2,300 | 0.0% | 0.00% | – |
| Q4 2015 | $3,000 | -94.7% | 2,300 | -91.1% | 0.00% | -100.0% |
| Q3 2015 | $57,000 | +338.5% | 25,700 | +350.9% | 0.00% | – |
| Q2 2015 | $13,000 | +1200.0% | 5,700 | +1040.0% | 0.00% | – |
| Q1 2015 | $1,000 | -50.0% | 500 | -37.5% | 0.00% | – |
| Q4 2014 | $2,000 | -85.7% | 800 | -84.9% | 0.00% | – |
| Q3 2014 | $14,000 | -76.7% | 5,300 | -67.1% | 0.00% | -100.0% |
| Q2 2014 | $60,000 | -84.8% | 16,100 | -52.1% | 0.00% | -85.7% |
| Q1 2014 | $395,000 | +375.9% | 33,600 | +239.4% | 0.01% | +600.0% |
| Q4 2013 | $83,000 | +418.8% | 9,900 | +518.8% | 0.00% | – |
| Q2 2013 | $16,000 | – | 1,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 5,300 | $14,000 | 0.00% |